Delaware: Dupixent (dupilumab) litigation | DrugsMonitor.com

Dupixent (dupilumab) litigation (DE) Delaware focus: docket-era primer, deadlines, case review—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, Delaware